Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

9th Imaging in Cancer Drug Development

13 Mar 2013 - 14 Mar 2013 - London, UK

Bookmark and Share

Join SMI at the anticipated 9th annual Imaging in Cancer Drug Development conference in March 2013 that will be the ultimate opportunity to witness presentations on the current developments surrounding oncology, pre-clinical & clinical imaging, technical innovations and advancements, imaging biomarkers in cancer drug development and the future of imaging. 

With a reputation for attracting the industry’s leading figures, this year's agenda offers an unmatched opportunity for debate and resolution of key challenges and current advances in oncology imaging. 


Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts

Novel target identification and lead discovery in preclinical biomarkers and radiochemistry

Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy

Overcoming challenges in nuclear tracers for multiscale imaging in oncology

Current application of PET/SPET modalities and a review of PFS (progression-free survival)

Practical tools for business expansion in the current economic climate

For more information visit

Or contact Cem Tuna on tel +44 0 207 827 6736 or email 

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos